FairJourneyBio logo

Display Platforms

Display Platforms

Every Display Technology. One Integrated Platform.

No single display technology is optimal for every target, format, or discovery objective. FairJourney Bio operates all four — and designs multi-platform strategies when the biology demands it.

Every Display Technology. One Integrated Platform.

No single display technology is optimal for every target, format, or discovery objective. FairJourney Bio operates all four — and designs multi-platform strategies when the biology demands it.

Every Display Technology. One Integrated Platform.

No single display technology is optimal for every target, format, or discovery objective. FairJourney Bio operates all four — and designs multi-platform strategies when the biology demands it.

Phage Display  

Fastest timelines, broadest library compatibility, most flexible panning strategy toolkit.


  • Formats: ScFv, Fab, VHH, VHH-Fc, biparatopic-VHH

  • Panning: solid-phase, in-solution, cell-based, pH-selective

  • Library access: Cosmic, SuperHuman 2.0, Explorer, Full Framework, llama naïve

  • Timeline: 6–8 weeks

Mammalian Display  

The antibody screened in its final therapeutic format on mammalian cells. Display level correlates with CMC behaviour. Patent-protected worldwide.


  • Library: 10⁶–10⁷ variants

  • Developability selection built in — not screened for retrospectively

  • Multi-parametric: affinity, developability, and function simultaneously

  • Timeline: 8–10 weeks

Yeast Display  

Quantitative FACS-based screening. Platform of choice for pH-switching, dual binders, and multi-condition selection.


  • Multi-parametric: affinity, dual-binding, pH-differential, cross-reactivity — simultaneously

  • Precise titration of selection stringency

  • Timeline: 8–10 weeks

Single B-Cell Screening  

Native antibody sequences from the immune response. Natively paired VH-VL preserved throughout.


  • 10⁶–10⁷ B-cells per run

  • Species: human patients and mice

  • B-cell populations: surface Ig and secretory Ig

  • Timeline: 8–10 weeks from terminal bleed

Explore BCell Navigator

Fullspectrum Characterization

fullspectrum-characterization

0

AnyFormat Manufacturing

anyformat-manufacturing

0

DeepDesign Engineering

deepdesign-engineering

0

FunctionInsight Assays

functioninsight-assays

0

B-Cell Navigator

b-cell-navigator

0

Solutions

solutions

1

Platforms & Technologies

platforms-technologies

0

Why FJBio

why-fjbio

0

Events & Resources

events-resources

0

Company

company

0

About

about

0

Antibody Discovery

antibody-discovery

0

Protein Production

protein-production

0

AtomicLevel Cryo-EM

atomic-level-cryo-em

0

FastTrack IND

fasttrack-ind

0

Biologistics

biologistics

0

Leadership

leadership

0

Careers

careers

0

News & Insights

news-insights

0

Case Studies

case-studies

0

Fact Sheets

fact-sheets

0

CellCraft Solutions

cellcraft-solutions

0

Cryo-EM

cryo-em

0

Display Platforms

display-platforms

0

Events

events

0

Library Diversity

library-diversity

0

MultiPath Discovery

multipath-discovery

0

Publications & Posters

publications-posters

0

Resources

resources

0

Screening | Analytics | Data Engines

screening-analytics-data-engines

0

Single B-Cell Screening

single-b-cell-screening

0

The Antibody Series Conference

the-antibody-series-conference

0

Tumbler™

tumbler

0

Webinars

webinars

0

White papers

whitepapers

0

Contact Us

contact-us

0